Menu
Selected examples of how we translate science into strategy execution.
Challenge
Late, fragmented stakeholder engagement limiting launch effectiveness across regions
Approach
Designed and implemented a structured, customer-centric early engagement model across the product lifecycle, enabling cross-functional alignment and stakeholder co-creation
Impact
Scaled globally across multiple affiliates, improving alignment, strengthening stakeholder relationships, and accelerating coordinated market entry
Challenge
Unclear evidence priorities for a late-stage innovative therapy, limiting readiness for clinical adoption and market access
Approach
Led a global, cross-functional data gap analysis integrating insights from international KOLs to define a prioritised evidence generation strategy
Impact
Established a clear and actionable evidence plan, strengthening the scientific narrative, supporting payer engagement, and enhancing global launch readiness
Challenge
Need for robust decision-making across multiple therapeutic assets and lifecycle stages
Approach
Conducted an end-to-end translational assessment from preclinical evidence to clinical and real-world relevance
Impact
Enabled informed go/no-go decisions, supported regulatory success, and identified new opportunities for product repositioning and differentiation
Challenge
Limited publication output and lack of structured evidence generation strategy
Approach
Delivered an end-to-end publication strategy, including systematic evidence synthesis, abstract development, and targeted journal and congress submissions
Impact
Rapidly established a high-quality publication pipeline, increasing scientific visibility and credibility across priority therapeutic areas
